Shikiar Asset Management Inc Incyte Corp Transaction History

Shikiar Asset Management Inc

$359 Million
Q2 2025

A detailed history of Shikiar Asset Management Inc transactions in Incyte Corp stock. As of the latest transaction made, Shikiar Asset Management Inc holds 113,995 shares of INCY stock, worth $8.94 Million. This represents 2.16% of its overall portfolio holdings.

Number of Shares

113,995

Previous 138,325 17.59%

Holding current value

$8.94 Million

Previous $8.38 Million 7.32%

% of portfolio

2.16%

Previous 2.5%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 24, 2025	SELL	$55.17 - $71.22 $1.34 Million - $1.73 Million	-24,330 Reduced 17.59%	113,995 $7.76 Million
Q1 2025 Apr 17, 2025	SELL	$60.0 - $75.26 $1.4 Million - $1.76 Million	-23,365 Reduced 14.45%	138,325 $8.38 Million
Q4 2024 Jan 15, 2025	SELL	$65.08 - $83.38 $357,614 - $458,173	-5,495 Reduced 3.29%	161,690 $11.2 Million
Q3 2024 Oct 10, 2024	BUY	$57.33 - $68.61 $295,822 - $354,027	5,160 Added 3.18%	167,185 $11.1 Million
Q2 2024 Jul 16, 2024	BUY	$51.18 - $63.75 $4.54 Million - $5.65 Million	88,675 Added 120.89%	162,025 $9.82 Million
Q1 2024 Apr 22, 2024	BUY	$56.55 - $66.59 $3.87 Million - $4.55 Million	68,350 Added 1367.0%	73,350 $4.18 Million
Q4 2023 Feb 01, 2024	SELL	$52.16 - $64.19 $78,240 - $96,285	-1,500 Reduced 23.08%	5,000 $314,000
Q1 2023 Apr 20, 2023	SELL	$70.23 - $86.01 $105,345 - $129,015	-1,500 Reduced 18.75%	6,500 $470,000
Q2 2022 Jul 15, 2022	SELL	$66.18 - $83.18 $57,907 - $72,782	-875 Reduced 9.86%	8,000 $608,000
Q1 2022 Apr 13, 2022	SELL	$66.02 - $79.71 $161,088 - $194,492	-2,440 Reduced 21.56%	8,875 $705,000
Q4 2021 Jan 21, 2022	SELL	$63.34 - $74.11 $628,649 - $735,541	-9,925 Reduced 46.73%	11,315 $830,000
Q3 2021 Oct 29, 2021	SELL	$68.67 - $84.02 $294,594 - $360,445	-4,290 Reduced 16.8%	21,240 $1.46 Million
Q2 2021 Jul 16, 2021	BUY	$79.87 - $87.53 $21,564 - $23,633	270 Added 1.07%	25,530 $2.15 Million
Q1 2021 May 05, 2021	BUY	$76.02 - $100.5 $427,232 - $564,810	5,620 Added 28.62%	25,260 $2.05 Million
Q4 2020 Feb 03, 2021	SELL	$80.74 - $97.7 $5.76 Million - $6.97 Million	-71,290 Reduced 78.4%	19,640 $1.71 Million
Q3 2020 Oct 28, 2020	BUY	$85.07 - $109.69 $6.73 Million - $8.68 Million	79,140 Added 671.25%	90,930 $8.16 Million
Q2 2020 Aug 20, 2020	SELL	$74.18 - $108.93 $221,798 - $325,700	-2,990 Reduced 20.23%	11,790 $1.23 Million
Q1 2020 May 01, 2020	SELL	$63.18 - $85.97 $5.47 Million - $7.45 Million	-86,635 Reduced 85.43%	14,780 $1.08 Million
Q4 2019 Jan 28, 2020	BUY	$73.04 - $95.72 $5.84 Million - $7.65 Million	79,915 Added 371.7%	101,415 $8.86 Million
Q3 2019 Oct 29, 2019	SELL	$72.82 - $86.52 $72,820 - $86,520	-1,000 Reduced 4.44%	21,500 $1.6 Million
Q2 2019 Jul 25, 2019	SELL	$73.52 - $88.7 $808,720 - $975,700	-11,000 Reduced 32.84%	22,500 $1.91 Million
Q1 2019 Apr 30, 2019	BUY	$63.56 - $88.17 $673,736 - $934,602	10,600 Added 46.29%	33,500 $2.88 Million
Q4 2018 Feb 01, 2019	SELL	$58.5 - $69.94 $427,050 - $510,562	-7,300 Reduced 24.17%	22,900 $1.46 Million
Q3 2018 Nov 05, 2018	SELL	$61.75 - $74.23 $5.13 Million - $6.16 Million	-83,000 Reduced 73.32%	30,200 $2.09 Million
Q2 2018 Jul 27, 2018	BUY	$60.85 - $83.98 $5.8 Million - $8.01 Million	95,350 Added 534.17%	113,200 $7.58 Million
Q1 2018 Apr 16, 2018	SELL	$83.06 - $100.98 $83,060 - $100,980	-1,000 Reduced 5.31%	17,850 $1.49 Million
Q4 2017 Jan 26, 2018	SELL	$93.56 - $116.6 $1.08 Million - $1.34 Million	-11,500 Reduced 37.89%	18,850 $1.79 Million
Q3 2017 Oct 20, 2017	BUY	$109.15 - $138.27 $3.31 Million - $4.2 Million	30,350	30,350 $3.54 Million

Others Institutions Holding INCY

# of Institutions

707

Shares Held

195M

Call Options Held

564K

Put Options Held

317K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $17.4B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shikiar Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Shikiar Asset Management Inc with notifications on news.

Account

Shikiar Asset Management Inc Incyte Corp Transaction History